The indian pharma

  Stelara (ustekinumab) is a prescription medication that is used to treat a variety of inflammatory conditions, including psoriasis, psoriatic arthritis, and Crohn's disease. It is given as an injection and works by targeting certain proteins in the body that contribute to inflammation. Stelara is administered as an injection under the skin (subcutaneous injection) or as an intravenous infusion (injection into a vein) by a healthcare professional. The dosage and frequency of the injection depends on the specific condition being treated and other factors such as the patient's weight and medical history. Common side effects of Stelara include headache, fatigue, nausea, and upper respiratory tract infections. Serious side effects can occur, such as serious allergic reactions or infections, including tuberculosis (TB), bacterial, viral, and fungal infections, which can be life-threatening. Stelara should not be used in people with a known hypersensitivity to ustekinumab or an...

Retevmo (selpercatinib) is a medication used in the treatment of several types of cancer, including non-small cell lung cancer (NSCLC) and thyroid cancer. Retevmo works by blocking certain proteins that contribute to the growth and spread of cancer cells. Some of the common side effects of Retevmo may include: 1. Diarrhea 2. Nausea and vomiting 3. Constipation 4. Abdominal pain 5. Dry mouth 6. Loss of appetite 7. Fatigue 8. Increased blood pressure 9. Headache 10. Weight gain More serious side effects may include: 1. Severe allergic reactions, such as hives, difficulty breathing, and swelling of the face, lips, tongue, or throat 2. Changes in heart rhythm or function, which can lead to heart failure or cardiac arrest 3. Liver problems, such as elevated liver enzymes, liver failure, or hepatitis 4. Lung problems, such as pneumonitis or interstitial lung disease 5. Increased risk of bleeding, such as from the gastrointestinal tract or brain It is important to discuss any potential sid...

  Tukysa (tucatinib) is a medication used in the treatment of HER2-positive breast cancer, which is a type of cancer that overexpresses the HER2 protein. Tukysa works by blocking the activity of HER2 protein, thereby preventing the growth and spread of cancer cells. Tukysa is available as an oral tablet, usually taken twice daily in combination with other medications, including trastuzumab and capecitabine. The specific dosage and duration of treatment may vary depending on the patient's individual factors, including their weight, overall health, and response to treatment. Like all medications, Tukysa can have potential side effects. Some of the more common ones include diarrhea, nausea, fatigue, and vomiting. More serious side effects may include liver problems, lung problems, and an increased risk of infections. It is important to discuss any potential side effects or concerns with your healthcare provider before starting treatment with Tukysa . As for the cost of Tukysa , thi...

  Enhertu (trastuzumab deruxtecan) is a medication used to treat HER2-positive breast cancer, which is a type of cancer that overexpresses the HER2 protein. It works by delivering a chemotherapy drug directly to the HER2-positive cancer cells, causing them to die. Enhertu is typically administered as an intravenous (IV) infusion over a period of several hours. The recommended dose of Enhertu is 5.4 mg/kg (up to a maximum of 600 mg) every three weeks, but the actual dosage and treatment duration may vary depending on the patient's individual factors, including their weight, overall health, and response to treatment. Like all medications, Enhertu can have potential side effects. Some of the more common ones include nausea, vomiting, diarrhea, and fatigue. More serious side effects may include heart problems, lung problems, and blood disorders. It is important to discuss any potential side effects or concerns with your healthcare provider before starting treatment with Enhertu . A...

  Stelara (ustekinumab) is a medication used to treat several autoimmune diseases, including psoriasis, psoriatic arthritis, and Crohn's disease. It works by blocking the activity of certain proteins in the body that contribute to inflammation and immune system dysfunction. Side Effects: Common side effects of Stelara include injection site reactions, headache, fatigue, and upper respiratory infections. More serious side effects may include an increased risk of infection, allergic reactions, and an increased risk of certain types of cancer. Dosage: The dosage of Stelara may vary depending on the specific condition being treated and the patient's weight. It is typically administered as an intravenous (IV) infusion or a subcutaneous injection. The initial dose is usually higher, followed by maintenance doses at regular intervals. Cost: The cost of Stelara can vary depending on several factors, including the dosage, the frequency of treatment, and the patient's insurance cove...

Xeljanz (Tofacitinib)- An Overview: Xeljanz contains active salt tofacitinib. It was the first FDA-approved tablet of its kind (JAK inhibitor). The medicine has been prescribed for beyond 9 years, since initial approval in 2012, for treating moderate to severe rheumatoid arthritis (RA). Xeljanz (tofacitinib) was approved for the treatment of adults with active psoriatic arthritis in 2017, adults with moderate to severe ulcerative colitis in 2018, and adults with active ankylosing spondylitis in 2021. In 2020, the medicine was approved for the treatment of children ages 2 years and older with active polyarticular course juvenile idiopathic arthritis. Tofacitinib Uses, Side Effects & Warnings Xeljanz (Tofacitinib) Uses: Xeljanz is a pill approved for the treatment of adults when a TNF inhibitor did not work well or could not be tolerated with: Moderate to Severe Rheumatoid Arthritis Moderate to Severe Ulcerative Colitis Active Psoriatic Arthritis Active Ankylosing Spondylitis Xelja...

  Carfilzomib 60 mg injection is a medication used in the treatment of multiple myeloma, a type of cancer that affects plasma cells in the bone marrow. It works by blocking certain enzymes in the body that contribute to the growth and spread of cancer cells. Carfilzomib is typically given as an intravenous (IV) injection or infusion over a period of several minutes. The specific dosing and duration of treatment may vary depending on the patient's response to treatment and any potential side effects that may occur. Like all medications, carfilzomib can have potential side effects. Some of the more common ones include fatigue, nausea, diarrhea, and low blood cell counts. More serious side effects may include heart problems, lung problems, and blood clots. It is important to discuss any potential side effects or concerns with your healthcare provider before starting treatment with carfilzomib . Carfilzomib is typically administered by a healthcare professional in a hospital or cli...